gh55

Advanced Solid Tumors With MAPK Signal Pathway Mutations

Tyligand Bioscience (Shanghai) LimitedPhase 1/2

—

Rating in progress

gh55 in Advanced Solid Tumors With MAPK Signal Pathway Mutations is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.

Methodology v0.2 · Active